Sarah F. Mercaldo

Sarah F. Mercaldo

Auto-generated profile, based on publicly available information

Sarah F. Mercaldo

Harvard Medical School, Boston, United States

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Radiology
Verified
Journal Article
Closed access
DSDorothy A. Sippo
Dorothy A. Sippo
KBKristine S. Burk
Kristine S. Burk
SMSarah F. Mercaldo
Sarah F. Mercaldo
GRGeoffrey M. Rutledge
Geoffrey M. Rutledge
CEChristine Edmonds
Christine Edmonds
CLConstance D. Lehman
Constance D. Lehman
This study found no evidence of a difference in screening breast MRI performance between women with BRCA mutation or history of chest radiation, personal history of breast cancer, and personal hist... BackgroundScreening breast MRI is recommended for women with BRCA mutation or a history of chest radiation, but guidelines are equivocal for MRI screening of women with a personal history of breast...

1 June 2020 in Radiology
Verified
Journal Article
Closed access
MBManisha Bahl
Manisha Bahl
SMSarah Mercaldo
Sarah Mercaldo
PDPragya A. Dang
Pragya A. Dang
AMAnne Marie McCarthy
Anne Marie McCarthy
KLKathryn P. Lowry
Kathryn P. Lowry
CLConstance D. Lehman
Constance D. Lehman
The benefits of reduced false-positive examinations and higher specificity with screening digital breast tomosynthesis were sustained after the first screening round. Background Performance metrics with digital breast tomosynthesis (DBT) are based on early experiences. There is limited research on whether the benefits of DBT are sustained. Purpose To determine w...

1 February 2021 in Radiology
Verified
Journal Article
Closed access
MBManisha Bahl
Manisha Bahl
SMSarah Mercaldo
Sarah Mercaldo
AMAnne Marie McCarthy
Anne Marie McCarthy
CLConstance D. Lehman
Constance D. Lehman
Among breast cancer survivors, digital breast tomosynthesis had a lower abnormal interpretation rate and higher specificity. Background Among breast cancer survivors, detecting a breast cancer when it is asymptomatic (rather than symptomatic) improves survival; thus, imaging surveillance in these patients is warranted. D...

1 July 2022 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
JCJacqueline M. Charvat
Jacqueline M. Charvat
DLDavid Leonard
David Leonard
CBCarolyn Elizabeth Barlow
Carolyn Elizabeth Barlow
LDLaura F. DeFina
Laura F. DeFina
BWBenjamin L. Willis
Benjamin L. Willis
MBMary Van Baalen
Mary Van Baalen

26 April 2021 in Respiratory Research
Verified
Journal Article
Open access
PDF file
ASAngela R. Shih
Angela R. Shih
CNChayanin Nitiwarangkul
Chayanin Nitiwarangkul
BLBrent P. Little
Brent P. Little
BRBenjamin W. Roop
Benjamin W. Roop
SNSreyankar Nandy
Sreyankar Nandy
LHLida P. Hariri
Lida P. Hariri
Background: Accurate diagnosis of idiopathic pulmonary fibrosis (IPF) is essential to inform prognosis and treatment. In 2018, the ATS/ERS/JRS/ALAT and Fleischner Society released new diagnostic guidelines for usual interstitial pneumonitis (UIP)/IPF, adding Probable UIP as a CT category based on prior studies demonstrating this category had relatively high positive predictive value (PPV) for histopathologic UIP/Probable UIP. This study applies the 2018 ATS/ERS/JRS/ALAT and Fleischner Society guidelines to determine test characteristics of CT categories in academic clinical practice. Methods: CT and histopathology were evaluated by three thoracic radiologists and two thoracic pathologists. Comparison of consensus categorization by the 2018 ATS and Fleischner Society guidelines by CT and histopathology was performed. Results: Of patients with CT UIP, 87% (PPV, 95% CI: 60–98%) had histopathologic UIP with 97% (CI: 90–100%) specificity. Of patients with CT Probable UIP, 38% (PPV, CI: 14–68%) had histopathologic UIP and 46% (PPV, CI: 19–75%) had either histopathologic UIP or Probable UIP, with 88% (CI: 77–95%) specificity. Patients with CT Indeterminate and Alternative Diagnosis had histopathologic UIP in 27% (PPV, CI: 6–61%) and 21% (PPV, CI: 11–33%) of cases with specificities of 90% (CI: 80–96%) and 25% (CI: 16–37%). Interobserver variability (kappa) between radiologists ranged 0.32–0.81. Conclusions: CT UIP and Probable UIP have high specificity for histopathologic UIP, and CT UIP has high PPV for histopathologic UIP. PPV of CT Probable UIP was 46% for combined histopathologic UIP/Probable UIP. Our results indicate that additional studies are needed to further assess and refine the guideline criteria to improve classification performance.

1 June 2019 in Radiology
Verified
Journal Article
Closed access
MBManisha Bahl
Manisha Bahl
NPNiveditha Pinnamaneni
Niveditha Pinnamaneni
SMSarah Mercaldo
Sarah Mercaldo
AMAnne Marie McCarthy
Anne Marie McCarthy
CLConstance D. Lehman
Constance D. Lehman
In women aged 65 years and older, digital breast tomosynthesis led to improved screening performance metrics, with a lower abnormal interpretation rate, higher positive predictive value 1, and higher specificity. BackgroundAlthough breast cancer incidence and mortality rates increase with advancing age, there are limited data on the benefits and risks of screening mammography in older women and on the performance of two-dimensional digital mammography (DM) and digital breast tomosynthesis (DBT) in older women.PurposeTo compare performance metrics of DM and DBT among women aged 65 years and older.Materials and MethodsFor this retrospective study, consecutive screening mammograms in patients aged 65 years and older from March 2008 to February 2011 (DM group) and from January 2013 to December 2015 (DBT group) were reviewed. Cancer detection rate, abnormal interpretation rate, positive predictive values, sensitivity, and specificity were calculated. Multivariable logistic regression models were fit to compare performance metrics in the DM versus DBT groups.ResultsThe DM group had 15 019 women (mean age ± standard deviation, 72.7 years ± 6.3), and the DBT group had 20 646 women (mean age, 72.1 years ± 5.9). After adjus...